학술논문
506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors
Document Type
article
Author
Anna Olsson-Brown; Joseph Sacco; Mark Middleton; Jason Chesney; Mohammed Milhem; Kevin Harrington; Robert Coffin; Katy Tsai; Adel Samson; Bartosz Chmielowski; Ari VanderWalde; Andrea Pirzkall; Jiaxin Niu; Praveen Bommareddy; Georgia Beasley; Gino In; Terence Rhodes; Francesca Aroldi; Lavita Menezes; Tawnya Bowles; Hamid Emamekhoo; Scott Baum; Sophie Dalac-Rat; Katharina Kahler; Eva Muñoz
Source
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Subject
Language
English
ISSN
2051-1426